BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Paliperidone (Invega) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Paliperidone (Invega)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04478838-9376@assetmemo.bio
DTSTAMP:20261121T005017Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Paliperidone (Invega): Phase 4 readout est. (NCT04478838)
DESCRIPTION:Paliperidone (Invega)\, phase 4\, Schizophrenia.\nStudy: "Exten
 ded" (Alternate Day) Antipsychotic Dosing\nEstimated primary completion: 3
 0 September 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/pal
 iperidone-invega#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT04478838
URL:https://assetmemo.bio/drug/paliperidone-invega#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
